[Congressional Record Volume 169, Number 122 (Monday, July 17, 2023)]
[House]
[Pages H3641-H3642]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

           By Ms. SLOTKIN:
       H.R. 4692.
       Congress has the power to enact this legislation pursuant 
     to the following:
       To make all Laws which shall be necessary and proper for 
     carrying into Execution the foregoing Powers, and all other 
     Powers vested by this Constitution in the Government of the 
     United States, or in any Department or Officer thereof.
       The single subject of this legislation is:
       This bill will restrict pharmacutical companies from 
     abusing their Risk Evaluation and Mitigation Strategy (REMS) 
     program to slow or block generic medications from entering 
     the market.

[[Page H3642]]

  

                          ____________________